Unable to attend the Office of Research CPH presentation on contracts?

Click the video above to watch or visit the Research SharePoint site to access the YouTube research channel under resources.

Appalachian Translational

Research Network (ATRN) Summit!

November 14th-15th, 2022

The 2022 ATRN Summit will be hosted by the University of Kentucky CCTS, and will be held at the Gatton Student Center on campus.

The KY Cabinet for Health & Family Services (CHFS) is once again soliciting proposals for consideration under their State University Partnership (SUP) mechanism. CHFS has used this program in the past to solicit projects that are of interest to their mission, especially serving Medicaid enrollees. They are able to draw down 50/50 federal matching monies, and academic institutions are required to put forward the matching funds (must be non-federal dollars; if you plan to use your state salary as the match, you may want to check with your department chair or dean). 

CHFS is only asking for 2-page proposals that fit within their interest areas and NOT full proposals, with a budget. The pdf “Research Topics for Universities” outlines specific interests, but CHFS has indicated that they are open to considering other proposals. The WORD document “SUP_Proposal_Tmp 2022 v2.0.docx” should be used to prepare the 2-page proposals.

Please submit your 2-page proposals directly to CHFS by Friday, July 15^th. Proposals should be emailed to jilnar.masri@ky.gov, cc’ing carrie.banahan@ky.gov and jrichardson@ky.gov.

Since these 2-pagers are essentially letters of intent without a specific budget request, it is not necessary to obtain OSPA review at this point. If you receive a subsequent request from CHFS to submit a more detailed proposal and budget, you will then need to seek appropriate approvals through OSPA’s regular eIAF process.

If you have questions about this mechanism, please reach out to Teresa Waters (teresa.waters@uky.edu) or Jeff Talbert (jeff.talbert@uky.edu).

Description: The purpose of this funding opportunity announcement (FOA) is to solicit applications for pragmatic clinical trials to decrease or prevent negative clinical outcomes due to vascular contributions to cognitive impairment and dementia (VCID), including locally representative NIH defined populations that experience health disparities in dementia. Examples of responsive projects and interventions that affect VCID outcomes include, but are not limited to, blood pressure control implementation; lifestyle modification using aerobic exercise; and early detection and treatment of VCID risk factors.

Activity Code:  U01 Research Project – Cooperative Agreements

Announcement Number: RFA-NS-23-001

Closing Date: September 15, 2022 

Description: This Funding Opportunity Announcement (FOA) invites applications to establish a network that will conduct transdisciplinary aging diagnostic biomarker and/or imaging research projects focused on Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) in persons living with multiple chronic conditions (MCCs). The aim of the network and its projects is to better align diagnostic testing with the needs and priorities of an aging population. The national consortium will: 1) assemble existing data and acquire real-world data to ensure that the research sample is large with adequate representation of older adults living with well-characterized MCCs, and incorporate pre-specified subgroup analyses; 2) analyze data for performance and accuracy of biomarkers, including blood, cerebrospinal fluid (CSF), and imaging, in older patients living with MCCs; and 3) conduct pilot studies involving specific AD/ADRD imaging and/or biomarkers in persons living with MCCs.

Activity Code: U24 Resource-Related Research Projects – Cooperative Agreements

Announcement Number: RFA-AG-23-032

Closing Date: October 17, 2022

Notice Number: NOT-OD-22-154

First Available Due Date: October 05, 2022

Expiration Date: September 08, 2025

Purpose: The purpose of this NOSI is to solicit projects on preventive interventions that address cardiometabolic risk factors in populations that experience health disparities.

Related Announcements

PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)

PA-20-184- Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)

PA-21-110 - Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

PAR-22-105 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

PAR-19-309 - Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

PAR-20-052 - NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

PAR-21-035 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

PAR-21-190 - Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

PAR-21-341 - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PAR-21-160 - NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-21-317 - NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

NOT-HL-20-788 - Notice of Special Interest (NOSI): Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations

PAR-20-150 - NIMHD Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional)

PAR-20-310 - Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional)

PAR-21-081 - Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)

PAR-21-287 - Effectiveness of School-Based Health Centers to Advance Health Equity (R01Clinical Trial Optional)

PAR-21-358 - Risk and Protective Factors of Family Health and Family Level Intervention (R01 Clinical Trial Optional)